000623.SZ
Jilin Aodong Pharmaceutical Group Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 16.70
−0.54%Oct 29, 2026, 07:57 UTC
Jilin Aodong reported first-nine-month 2026 revenue of 1.543 billion yuan, down 5.92% year over year, and attributable net profit of 2.858 billion yuan, up 26.42%.
Source:Oct 29, 2026, 07:57 UTC
Jilin Aodong reported third-quarter 2026 revenue of 512 million yuan, down 0.32% year over year, and attributable net profit of 808 million yuan, down 17.48%.
Source:Aug 28, 2026, 10:44 UTC
Jilin Aodong proposed a cash dividend of 2 yuan per 10 shares (tax included), based on 1.172 billion shares outstanding as of June 30, 2026.
Source:Aug 28, 2026, 10:44 UTC
Jilin Aodong announced its first-half 2026 results: net profit attributable to shareholders was 2.05 billion yuan, up 59.96% year-on-year, with revenue of 1.031 billion yuan, down 8.47%.
Source: